Connect with us

Health

Antiviral compound GC-376 shows efficacy against SARS-CoV-2 in vivo – News-Medical.Net

Over the past months, many potential antivirals against SARS-CoV-2 have been identified as deserving further development to target several viral proteins. A new…

Published

on

post featured image

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, has dominated human life all over the world for almost a year. Since the identification of this illness in December 2019, it has taken over 2.2 million lives. Meanwhile, immense economic stress has resulted from the severe restrictions imposed upon human mobility and physical interactions outside one’s own family or household to contain the spread of the virus.
Schematic…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending